US Stock MarketDetailed Quotes
RNAC Cartesian Therapeutics
- 18.870
- +2.250+13.54%
Close Nov 22 16:00 ET
- 18.870
- 0.0000.00%
Post 16:01 ET
479.58MMarket Cap-408P/E (TTM)
19.045High16.500Low65.82KVolume16.560Open16.620Pre Close1.17MTurnover0.72%Turnover RatioLossP/E (Static)25.41MShares41.87052wk High629.00P/B172.35MFloat Cap11.66552wk Low--Dividend TTM9.13MShs Float728.003Historical High--Div YieldTTM15.31%Amplitude11.665Historical Low17.826Avg Price1Lot Size
Cartesian Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -94.09%387K | 537.17%33.45M | -1.65%5.84M | -76.53%26M | -50.78%8.27M | -68.37%6.55M | -86.63%5.25M | -82.53%5.94M | 30.21%110.78M | -43.90%16.8M |
| Operating revenue | -94.09%387K | 537.17%33.45M | -1.65%5.84M | -76.53%26M | -50.78%8.27M | -68.37%6.55M | -86.63%5.25M | -82.53%5.94M | 30.21%110.78M | -43.90%16.8M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -8.43%17.96M | -17.58%19.69M | -21.10%19.19M | 16.81%112.42M | 76.34%44.6M | -12.07%19.62M | -6.00%23.89M | 4.71%24.32M | 7.32%96.24M | -2.20%25.29M |
| Selling and administrative expenses | -0.79%6.56M | 15.10%7.03M | 65.94%9.45M | 70.07%40.58M | 250.52%22.17M | 14.63%6.61M | -2.02%6.11M | 2.85%5.7M | 13.97%23.86M | 14.13%6.32M |
| -General and administrative expense | -0.79%6.56M | 15.10%7.03M | 65.94%9.45M | 70.07%40.58M | 250.52%22.17M | 14.63%6.61M | -2.02%6.11M | 2.85%5.7M | 13.97%23.86M | 14.13%6.32M |
| Research and development costs | -12.32%11.4M | -28.80%12.66M | -47.71%9.74M | -0.74%71.84M | 18.26%22.43M | -21.39%13M | -7.30%17.78M | 5.29%18.62M | 5.30%72.38M | -6.65%18.97M |
| Operating profit | -34.52%-17.58M | 173.81%13.76M | 27.38%-13.35M | -694.41%-86.42M | -327.64%-36.33M | -717.07%-13.07M | -234.47%-18.64M | -270.62%-18.38M | 416.25%14.54M | -308.34%-8.5M |
| Net non-operating interest income expense | 0 | 0 | 0 | 6.53%-2.83M | 0 | -58.73%-1.27M | -5.17%-752K | -14.29%-808K | -6.58%-3.03M | -13.50%-807K |
| Non-operating interest expense | --0 | --0 | --0 | -6.53%2.83M | --0 | 58.73%1.27M | 5.17%752K | 14.29%808K | 6.58%3.03M | 13.50%807K |
| Other net income (expense) | -223.84%-6.61M | -99.01%79K | -1,657.32%-43.48M | -742.48%-149.46M | -1,175.44%-160.33M | 191.79%5.34M | 276.12%8M | -113.22%-2.47M | 1,120.31%23.26M | 65.46%14.91M |
| Gain on sale of security | 62.15%8.24M | -134.97%-2.71M | -71.64%-4.68M | -674.94%-131.85M | -1,063.58%-141.96M | 187.43%5.08M | 270.73%7.76M | -114.71%-2.73M | 1,099.26%22.93M | 63.52%14.73M |
| Special income (charges) | ---15.1M | --2.5M | ---39.3M | ---18.3M | ---18.3M | --0 | --0 | --0 | --0 | ---- |
| -Less：Restructuring and merger&acquisition | --15.1M | ---2.5M | --39.3M | --18.3M | --18.3M | --0 | --0 | --0 | --0 | ---- |
| Other non- operating income (expenses) | -1.19%250K | 19.18%292K | 99.22%508K | 109.39%691K | -135.43%-62K | 25,200.00%253K | --245K | 65.58%255K | 2,100.00%330K | --175K |
| Income before tax | -168.64%-24.18M | 221.51%13.84M | -162.31%-56.82M | -786.54%-238.71M | -3,608.62%-196.66M | -9.59%-9M | -232.39%-11.39M | -175.28%-21.66M | 457.68%34.77M | -54.71%5.61M |
| Income tax | -3,019.87%-19M | -103.81%-609K | -308.70%-288K | |||||||
| Net income | -168.64%-24.18M | 221.51%13.84M | -162.31%-56.82M | -721.02%-219.71M | -3,114.73%-177.66M | -14.05%-9M | -232.39%-11.39M | -175.28%-21.66M | 237.73%35.38M | -51.85%5.89M |
| Net income continuous Operations | -168.64%-24.18M | 221.51%13.84M | -162.31%-56.82M | -721.02%-219.71M | -3,114.73%-177.66M | -14.05%-9M | -232.39%-11.39M | -175.28%-21.66M | 237.73%35.38M | -51.85%5.89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -168.64%-24.18M | 221.51%13.84M | -162.31%-56.82M | -721.02%-219.71M | -3,114.73%-177.66M | -14.05%-9M | -232.39%-11.39M | -175.28%-21.66M | 237.73%35.38M | -51.85%5.89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 4.21M | 0 | ||||||||
| Net income attributable to common stockholders | -168.64%-24.18M | 184.55%9.63M | -162.31%-56.82M | -721.02%-219.71M | -3,114.73%-177.66M | -14.05%-9M | -232.39%-11.39M | -175.28%-21.66M | 237.73%35.38M | -51.85%5.89M |
| Basic earnings per share | -94.83%-3.39 | 126.01%0.58 | -147.64%-10.5 | -791.67%-49.8 | -4,722.22%-41.6 | -16.00%-1.74 | -223.89%-2.23 | -161.45%-4.24 | 209.09%7.2 | -70.00%0.9 |
| Diluted earnings per share | -94.83%-3.39 | 124.22%0.54 | -147.64%-10.5 | -1,760.00%-49.8 | -2,673.33%-41.6 | -16.00%-1.74 | -223.89%-2.23 | -276.67%-4.24 | 145.45%3 | -266.67%-1.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
